Herbalife Nutrition Ltd. (HLF)

Deep-value, cash-generative nutrition company mid-turnaround: the April 2026 refinancing replaced punitive 12.25% debt with 7.75% notes due 2033, revenue inflected positive in H1 2026, and trailing free cash flow yields roughly 25%. No going-concern issues and covenant-compliant; main caveats are negative book equity, elevated leverage, MLM regulatory/legal overhang, and a CEO transition.

Dominant announced catalyst is the planned CEO transition (2026-08-31; bearish reception — shares gapped down ~11.6% with coverage scored −0.2 to −0.45), conflicting with an in-window bullish FY net-sales guidance raise (2026-08-26; +0.4 coverage) and a neutral Q3/FY guidance reaffirmation; media delta is determinate and deteriorating (+0.125 baseline → ≈ −0.12 scoring); moderate red-flag cap applied (conflicting catalysts); retail mention velocity indeterminate.

Bearish short-term structure: HLF closed 09-17 at 11.69 (-5.65%) below every key moving average (SMA20 12.18, SMA50 12.25, SMA200 14.11; EMA9 12.00, EMA21 12.11; WMA9/21, DEMA14, TEMA14 all above price). Momentum is negative and worsening: MACD line -0.10 below signal -0.05 with histogram -0.05, RSI 43.5, Williams %R -53.6, and ADX 9.1 shows no directional thrust in either direction. The 09-17 candle printed a two-week low at 11.65 and closed near the lows. No bullish setup qualifies: a pullback/oversold limit is countertrend (price below the SMA50 with MACD < 0) and not oversold; the only breakout trigger available (above the 09-17 high 12.40) is a countertrend entry into a down-trending stack with no momentum confirmation. Liquidity, event, gap and volatility gates all pass — the block is purely chart quality (score 2/5 < required 3).